Alzheimer's drug may help battle antibiotic resistance

Alzheimer's drug may help battle antibiotic resistance
Credit: University of Queensland

Dangerous antibiotic-resistant bacteria could soon be targeted with a drug initially developed to treat Alzheimer's disease.

University of Queensland-led research investigated the antibacterial properties of metal transport drug, PBT2.

Professor Mark Walker from UQ's School of Chemistry and Molecular Biosciences said while the drug did not make it to market for Alzheimer's and Huntington's disease, the results suggest it may still have great use.

"This particular drug progressed to phase one and two for Alzheimer's and Huntington's, and was shown to be well tolerated by human subjects," he said.

"PBT2 is designed to disrupt the interaction between metals and , which was thought would reduce heavy metal levels in the brain.

"With this in mind, and knowing that disrupting metal content can induce toxicity in bacteria, we examined the effects of PBT2 against a wide range of ."

The results indicated that the drug had the capacity to fight infectious diseases by breaking antibiotic-resistance in bacteria.

"Repurposing PBT2 as an 'antibiotic breaker' represents a new strategy in the fight against antibiotic-resistant bacteria," Professor Walker said.

"We may be able to reverse it in such a way that ineffective antibiotics become effective again in treating ."

Professor Mark von Itzstein from Griffith University said it was exciting news, given that is one of the greatest threats to global public health.

"Over the past 30 years, many species of bacteria have acquired resistance to a wide range of antibiotics," he said.

"This has rendered current antibiotic treatment therapies ineffective and led to increasing numbers of deaths due to infectious disease agents in Australia.

"If new solutions aren't developed, it's estimated that by 2050, antimicrobial-resistant will account for more than 10 million deaths per year.

"We've found one more weapon in our arsenal to help save millions of lives."


Explore further

Antibiotic-resistant bacteria now claiming 33,000 lives annually

More information: Lisa Bohlmann et al. Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance, mBio (2018). DOI: 10.1128/mBio.02391-18
Journal information: mBio

Citation: Alzheimer's drug may help battle antibiotic resistance (2018, December 12) retrieved 22 October 2019 from https://medicalxpress.com/news/2018-12-alzheimer-drug-antibiotic-resistance.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more